- Home
- LXRX vs EDF Comparison
LXRX vs EDF Comparison
Compare LXRX & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- EDF
- Stock Information
- Founded
- LXRX 1995
- EDF 2010
- Country
- LXRX United States
- EDF United States
- Employees
- LXRX N/A
- EDF N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- EDF Investment Managers
- Sector
- LXRX Health Care
- EDF Finance
- Exchange
- LXRX Nasdaq
- EDF Nasdaq
- Market Cap
- LXRX 124.4M
- EDF 148.8M
- IPO Year
- LXRX 2000
- EDF N/A
- Fundamental
- Price
- LXRX $0.50
- EDF $4.94
- Analyst Decision
- LXRX Buy
- EDF
- Analyst Count
- LXRX 4
- EDF 0
- Target Price
- LXRX $3.67
- EDF N/A
- AVG Volume (30 Days)
- LXRX 31.4M
- EDF 160.6K
- Earning Date
- LXRX 03-06-2025
- EDF 01-01-0001
- Dividend Yield
- LXRX N/A
- EDF 13.14%
- EPS Growth
- LXRX N/A
- EDF N/A
- EPS
- LXRX N/A
- EDF N/A
- Revenue
- LXRX $31,081,000.00
- EDF N/A
- Revenue This Year
- LXRX N/A
- EDF N/A
- Revenue Next Year
- LXRX $101.91
- EDF N/A
- P/E Ratio
- LXRX N/A
- EDF N/A
- Revenue Growth
- LXRX 2481.48
- EDF N/A
- 52 Week Low
- LXRX $0.28
- EDF $3.51
- 52 Week High
- LXRX $2.45
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- LXRX 53.54
- EDF 36.41
- Support Level
- LXRX $0.32
- EDF $5.07
- Resistance Level
- LXRX $0.71
- EDF $5.09
- Average True Range (ATR)
- LXRX 0.06
- EDF 0.10
- MACD
- LXRX 0.03
- EDF -0.02
- Stochastic Oscillator
- LXRX 46.95
- EDF 7.14
Stock Price Comparison Chart: LXRX vs EDF
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.